Ifat Sher

1.5k total citations
52 papers, 1.1k citations indexed

About

Ifat Sher is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ifat Sher has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 28 papers in Ophthalmology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ifat Sher's work include Retinal Development and Disorders (24 papers), Retinal Diseases and Treatments (21 papers) and Glaucoma and retinal disorders (16 papers). Ifat Sher is often cited by papers focused on Retinal Development and Disorders (24 papers), Retinal Diseases and Treatments (21 papers) and Glaucoma and retinal disorders (16 papers). Ifat Sher collaborates with scholars based in Israel, United States and United Kingdom. Ifat Sher's co-authors include Dina Ron, Ygal Rotenstreich, Michael Belkin, Brenda L. Coomber, Sirin A. Adham, Moosa Mohammadi, Brian Yeh, Avraham J. Treves, Amilia Meir and Arnon Nagler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Ifat Sher

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ifat Sher Israel 17 710 243 222 178 80 52 1.1k
Zahra‐Soheila Soheili Iran 18 600 0.8× 159 0.7× 59 0.3× 205 1.2× 90 1.1× 94 1.0k
A. Tyl Hewitt United States 20 571 0.8× 245 1.0× 322 1.5× 228 1.3× 55 0.7× 30 1.2k
Charlotte Andrieu‐Soler France 25 1.7k 2.3× 233 1.0× 651 2.9× 190 1.1× 61 0.8× 43 2.4k
Anastasios Georgiadis United Kingdom 18 1.3k 1.8× 289 1.2× 130 0.6× 182 1.0× 77 1.0× 32 1.5k
Raymond C.B. Wong Australia 27 1.5k 2.1× 200 0.8× 144 0.6× 131 0.7× 294 3.7× 79 1.9k
Shimpei Nishikawa Japan 20 1.0k 1.4× 227 0.9× 113 0.5× 170 1.0× 69 0.9× 50 1.7k
Kevin Gregory‐Evans Canada 17 634 0.9× 235 1.0× 88 0.4× 164 0.9× 25 0.3× 37 833
Carl Sheridan United Kingdom 23 684 1.0× 784 3.2× 111 0.5× 830 4.7× 75 0.9× 76 1.6k
Elaine Tan United States 22 778 1.1× 152 0.6× 391 1.8× 135 0.8× 25 0.3× 38 1.6k

Countries citing papers authored by Ifat Sher

Since Specialization
Citations

This map shows the geographic impact of Ifat Sher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ifat Sher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ifat Sher more than expected).

Fields of papers citing papers by Ifat Sher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ifat Sher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ifat Sher. The network helps show where Ifat Sher may publish in the future.

Co-authorship network of co-authors of Ifat Sher

This figure shows the co-authorship network connecting the top 25 collaborators of Ifat Sher. A scholar is included among the top collaborators of Ifat Sher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ifat Sher. Ifat Sher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sher, Ifat, et al.. (2025). In Vivo Imaging of Cobalt-Induced Ocular Toxicity in a Mouse Model. Methods and Protocols. 8(1). 1–1. 1 indexed citations
2.
Sher, Ifat, G Altmann, A Sabó, et al.. (2024). Housing RCS rats under specific pathogen-free conditions mildly ameliorates retinal degeneration and alters intestine microbiota. Scientific Reports. 14(1). 21583–21583. 1 indexed citations
3.
Goldberg, Zehavit, Amir Dori, Nicola Maggio, et al.. (2023). PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy. International Journal of Molecular Sciences. 24(3). 2021–2021. 1 indexed citations
4.
Rotenstreich, Ygal, et al.. (2023). A Novel Device for Suprachoroidal Drug Delivery to Retina: Evaluation in Nonhuman Primates. Translational Vision Science & Technology. 12(6). 3–3. 2 indexed citations
5.
Sher, Ifat, et al.. (2021). Suprachoroidal delivery of bevacizumab in rabbit in vivo eyes: Rapid distribution throughout the posterior segment. European Journal of Pharmaceutics and Biopharmaceutics. 169. 200–210. 3 indexed citations
6.
Sher, Ifat, et al.. (2020). In vivo retinal imaging in translational regenerative research. Annals of Translational Medicine. 8(17). 1096–1096. 2 indexed citations
7.
Sher, Ifat, et al.. (2020). Efficacy and safety of injecting increasing volumes into the extravascular spaces of the choroid using a blunt adjustable depth injector. International Ophthalmology. 40(11). 2865–2874. 2 indexed citations
8.
Afek, Arnon, Gilad Twig, Eran Pras, et al.. (2019). Myopia and Childhood Migration. Ophthalmology. 127(6). 713–723. 12 indexed citations
9.
Sher, Ifat, Estela Derazne, Eran Pras, et al.. (2019). <p>Chromatic pupilloperimetry for objective diagnosis of Best vitelliform macular dystrophy</p>. Clinical ophthalmology. Volume 13. 465–475. 8 indexed citations
10.
Sher, Ifat, Enav Corem‐Salkmon, Itay Levy, et al.. (2019). In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration. Journal of Nanobiotechnology. 17(1). 3–3. 36 indexed citations
11.
Sher, Ifat, et al.. (2016). Long-term treatment with 9-cis-β-carotene rich alga Dunaliella Bardawil inhibits photoreceptor degeneration in a mouse model of retinoid cycle defect. Investigative Ophthalmology & Visual Science. 57(12). 1 indexed citations
12.
Sher, Ifat, Asaf Achiron, Soad Haj Yahia, et al.. (2016). Chromatic Multifocal Pupillometer for Objective Perimetry and Diagnosis of Patients with Retinitis Pigmentosa. Ophthalmology. 123(9). 1898–1911. 24 indexed citations
13.
14.
Adham, Sirin A., Ifat Sher, & Brenda L. Coomber. (2010). Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells. Laboratory Investigation. 90(5). 709–723. 26 indexed citations
15.
Adham, Sirin A., Ifat Sher, & Brenda L. Coomber. (2009). Abstract #4284: Blockade of VEGFR2/KDR increases malignancy in human epithelial ovarian carcinoma. Cancer Research. 69. 4284–4284. 1 indexed citations
16.
Patel, Vaishali, Simona Zisman‐Rozen, Ifat Sher, et al.. (2008). Specific Heparan Sulfate Structures Modulate FGF10-mediated Submandibular Gland Epithelial Morphogenesis and Differentiation. Journal of Biological Chemistry. 283(14). 9308–9317. 87 indexed citations
17.
Shaoul, Ron, et al.. (2006). Elevated expression of FGF7 protein is common in human gastric diseases. Biochemical and Biophysical Research Communications. 350(4). 825–833. 28 indexed citations
18.
Sher, Ifat, Simona Zisman‐Rozen, John M. Whitelock, et al.. (2005). Targeting Perlecan in Human Keratinocytes Reveals Novel Roles for Perlecan in Epidermal Formation. Journal of Biological Chemistry. 281(8). 5178–5187. 81 indexed citations
19.
Sher, Ifat, Brian Yeh, Moosa Mohammadi, Noam Adir, & Dina Ron. (2003). Structure‐based mutational analyses in FGF7 identify new residues involved in specific interaction with FGFR2IIIb. FEBS Letters. 552(2-3). 150–154. 16 indexed citations
20.
Sher, Ifat, Jonathan Kuhn, Noam Adir, et al.. (2000). Identification of Residues Important Both for Primary Receptor Binding and Specificity in Fibroblast Growth Factor-7. Journal of Biological Chemistry. 275(45). 34881–34886. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zahra‐Soheila Soheili Breakdown of academic impact, for papers by A. Tyl Hewitt Breakdown of academic impact, for papers by Charlotte Andrieu‐Soler Breakdown of academic impact, for papers by Anastasios Georgiadis Breakdown of academic impact, for papers by Raymond C.B. Wong Breakdown of academic impact, for papers by Shimpei Nishikawa Breakdown of academic impact, for papers by Kevin Gregory‐Evans Breakdown of academic impact, for papers by Carl Sheridan Breakdown of academic impact, for papers by Elaine Tan
Rankless by CCL
2026